Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B

Stefan Zeuzem(Goethe University Frankfurt), Edward Gane(Middlemore Hospital), Yun‐Fan Liaw(Chang Gung Memorial Hospital), Seng Gee Lim(National University Hospital), A DIBISCEGLIE(Saint Louis University), Marı́a Buti(Vall d'Hebron Hospital Universitari), Anuchit Chutaputti(Phramongkutklao Hospital), J. Rasenack(University of Freiburg), Jinlin Hou(Nanfang Hospital), Christopher O’Brien(University of Miami), Tuan Nguyen, Jidong Jia(Capital Medical University), Thierry Poynard(Sorbonne Université), Bruce Belanger(Idera Pharmaceuticals (United States)), Weibin Bao(Novartis (United States)), Nikolai V. Naoumov(Novartis (Switzerland))
Journal of Hepatology
February 13, 2009
Cited by 195

Abstract


Related Papers

No related papers found

Powered by citation graph analysis